126 related articles for article (PubMed ID: 9055218)
1. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR
Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218
[TBL] [Abstract][Full Text] [Related]
2. 19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine.
Krems B; Bachert P; Zabel HJ; Lorenz WJ
J Magn Reson B; 1995 Aug; 108(2):155-64. PubMed ID: 7648013
[TBL] [Abstract][Full Text] [Related]
3. Selective 19F MR imaging of 5-fluorouracil and alpha-fluoro-beta-alanine.
Brix G; Bellemann ME; Zabel HJ; Bachert P; Lorenz WJ
Magn Reson Imaging; 1993; 11(8):1193-201. PubMed ID: 8271906
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Gonen O; Murphy-Boesch J; Li CW; Padavic-Shaller K; Negendank WG; Brown TR
Magn Reson Med; 1997 Feb; 37(2):164-9. PubMed ID: 9001138
[TBL] [Abstract][Full Text] [Related]
5. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
6. Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
Brix G; Bellemann ME; Haberkorn U; Gerlach L; Bachert P; Lorenz WJ
Magn Reson Med; 1995 Sep; 34(3):302-7. PubMed ID: 7500866
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
[TBL] [Abstract][Full Text] [Related]
8. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous 3D NMR spectroscopy of fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Li CW; Gonen O
Magn Reson Med; 1996 Jun; 35(6):841-7. PubMed ID: 8744011
[TBL] [Abstract][Full Text] [Related]
10. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
[TBL] [Abstract][Full Text] [Related]
11. Direct 19F NMR spectroscopic observation of 5-fluorouracil metabolism in the isolated perfused mouse liver model.
Cabanac S; Malet-Martino MC; Bon M; Martino R; Nedelec JF; Dimicoli JL
NMR Biomed; 1988 Jun; 1(3):113-20. PubMed ID: 3152774
[TBL] [Abstract][Full Text] [Related]
12. Complete urinary excretion profile of 5-fluorouracil during a six-day chemotherapeutic schedule, as resolved by 19F nuclear magnetic resonance.
Bernadou J; Armand JP; Lopez A; Malet-Martino MC; Martino R
Clin Chem; 1985 Jun; 31(6):846-8. PubMed ID: 3922650
[TBL] [Abstract][Full Text] [Related]
13. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
Martino R; Malet-Martino MC; Vialaneix C; Lopez A; Bon M
Drug Metab Dispos; 1987; 15(6):897-904. PubMed ID: 2893719
[TBL] [Abstract][Full Text] [Related]
14. Gallbladder localization of (19)F MRS catabolite signals in patients receiving bolus and protracted venous infusional 5-fluorouracil.
Dzik-Jurasz AS; Collins DJ; Leach MO; Rowland IJ
Magn Reson Med; 2000 Oct; 44(4):516-20. PubMed ID: 11025505
[TBL] [Abstract][Full Text] [Related]
15. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
[TBL] [Abstract][Full Text] [Related]
16. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
[TBL] [Abstract][Full Text] [Related]
17. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
[TBL] [Abstract][Full Text] [Related]
18. Excretion of 1-hexylcarbamoyl-5-fluorouracil in urine of mice.
Iigo M; Nakamura A; Kuretani K; Hoshi A
J Pharmacobiodyn; 1981 Jul; 4(7):490-6. PubMed ID: 6795334
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy.
Kamm YJ; Heerschap A; Rosenbusch G; Rietjens IM; Vervoort J; Wagener DJ
Magn Reson Med; 1996 Sep; 36(3):445-50. PubMed ID: 8875416
[TBL] [Abstract][Full Text] [Related]
20. 17O-decoupled 1H detection using a double-tuned coil.
Reddy R; Stolpen AH; Charagundla SR; Insko EK; Leigh JS
Magn Reson Imaging; 1996; 14(9):1073-8. PubMed ID: 9070998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
